Y. Seifu

发表

Fitting population dynamic models to time-series data by gradient matching

S. Ellner, Y. Seifu, Robert H. Smith, 2002 .

Persistent stress-induced elevations of urinary corticosterone in rats

R. Servatius, Y. Seifu, F. Brennan, 2000, Physiology & Behavior.

Nonparametric multivariate inference on shift parameters.

John E Kolassa, Y. Seifu, J. Kolassa, 2013, Academic radiology.

Statistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive of Fabrication or Misconduct

A. Lindblad, Y. Seifu, G. Gensler, 2016, Therapeutic innovation & regulatory science.

Enteric‐Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1‐Year Study

Y. Seifu, K. Budde, G. Knoll, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy and safety of a ready-to-drink bowel preparation for colonoscopy: a randomized, controlled, non-inferiority trial

Y. Seifu, L. Hookey, G. Bertiger, 2019, Therapeutic advances in gastroenterology.

Validation of the Differential Cardiovascular Effects of the Antimuscarinic Agents Darifenacin and Tolterodine in a Randomized, Placebo-Controlled, 3-Way Crossover Study

Y. Seifu, B. Olshansky, J. Brum, 2009 .

Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction

Akshay S. Desai, S. Solomon, A. Desai, 2010, Hypertension.

The win odds: statistical inference and regression

D. Hoaglin, Duolao Wang, Y. Seifu, 2022, Journal of biopharmaceutical statistics.

Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.

Y. Seifu, John K. Park, P. Heiser, 2020, Fertility and sterility.

Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.

Y. Seifu, K. Budde, G. Knoll, 2005, Transplantation proceedings.

Semiparametric Bayesian inference for regression models

M. Tanner, T. Severini, Y. Seifu, 1999 .

Using Spatial Statistics to Select Model Complexity

Y. Seifu, Stephen P.Ellner, Yodit Seifu, 2002 .

Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time‐to‐event outcomes

D. Hoaglin, Duolao Wang, Y. Seifu, 2022, Pharmaceutical statistics.

Initial Combination Therapy Compared With Monotherapy in Diabetic Hypertensive Patients

Y. Seifu, J. Sowers, G. Lastra, 2008, Journal of clinical hypertension.

Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy

S. Oparil, B. Pitt, Y. Seifu, 2011, Journal of Hypertension.

Real-World Evidence Utilization in Clinical Development Reflected by US Product Labeling: Statistical Review

Y. Seifu, Freda Cooner, Shiling Ruan, 2020, Therapeutic Innovation & Regulatory Science.

Managing Patients With ‘Wet’ Overactive Bladder: Results of Pooled Studies Show Efficacy of Darifenacin as Measured by ‘Dry Days’

Y. Seifu, D. Newman, L. Mongay, 2010 .

Time-to-effect with darifenacin in overactive bladder: a pooled analysis

Y. Seifu, V. Khullar, J. Foote, 2011, International Urogynecology Journal.

The win ratio: Impact of censoring and follow‐up time and use with nonproportional hazards

D. Hoaglin, Y. Seifu, Bo Huang, 2019, Pharmaceutical statistics.

Design of paediatric trials with benefit-risk endpoints using a composite score of adverse events of interest (AEI) and win-statistics.

Y. Seifu, J. Kolassa, S. Mt-Isa, 2022, Journal of Biopharmaceutical Statistics.

Guest editors’ note on special issue on application of estimand

Y. Seifu, William W. B. Wang, 2023, Journal of biopharmaceutical statistics.

Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).

Y. Seifu, K. Budde, G. Knoll, 2006, Clinical nephrology.

Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients.

M. Salvadori, Y. Seifu, H. Holzer, 2006, Clinical nephrology.

Efficacy and safety of a ready-to-drink bowel preparation for colonoscopy: a randomized, controlled, non-inferiority trial

Y. Seifu, L. Hookey, G. Bertiger, 2019, Therapeutic advances in gastroenterology.

The natural history of obstetrical brachial plexus palsy.

Y. Seifu, R. Zuker, H. Clarke, 1994, Plastic and reconstructive surgery.

Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction

Akshay S. Desai, S. Solomon, S. Oparil, 2010, Hypertension.

Initial Combination Therapy Compared With Monotherapy in Diabetic Hypertensive Patients

Y. Seifu, J. Sowers, G. Lastra, 2008, Journal of clinical hypertension.

Estimand in benefit-risk assessment

Y. Seifu, Xinru Ren, X. G. Chen, 2023, Journal of biopharmaceutical statistics.